Ezetimibe Synthesis via Palladium-Catalyzed Asymmetric Allylic Amination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic methods for Ezetimibe require the use of expensive and environmentally unfriendly chiral auxiliary agents to construct the key chiral C-4 in its β-lactam structure, which are not economically viable or environmentally friendly.
Innovation Solution
A novel synthetic method for Ezetimibe using a palladium-catalyzed asymmetric allylic amination process with a chiral aromatic spiroketal bisphosphine ligand, eliminating the need for chiral auxiliary agents and enabling catalytic asymmetric construction of the key chiral C-4.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If chiral auxiliary agents are used to construct the key chiral C-4 in Ezetimibe, then the chiral structure can be formed, but the synthesis becomes expensive and environmentally unfriendly
Solution Approach 1:
The invention extracts and removes the chiral auxiliary agents from the synthesis process entirely. Instead of using traditional chiral auxiliaries like oxazolidinone or hydroxy-butyrolactone, the method employs a palladium-catalyzed asymmetric allylic amination reaction that directly constructs the chiral C-4 center without requiring these auxiliary substances, thereby eliminating their associated costs and environmental burdens
Solution Approach 2:
The invention changes the fundamental reaction mechanism from auxiliary-based chiral induction to catalytic asymmetric synthesis. By using a palladium catalyst with chiral ligands, the reaction parameters are transformed to achieve enantioselectivity through catalytic action rather than stoichiometric auxiliary agents, reducing material consumption and waste
2Manufacturing precision
If traditional synthetic routes are used for Ezetimibe, then the chiral C-4 can be constructed, but the process requires multiple steps and complex procedures
Solution Approach 1:
The invention merges the chiral induction function and the C-4 construction function into a single catalytic reaction step. The palladium-catalyzed asymmetric allylic amination simultaneously forms the chiral center and constructs the molecular framework, eliminating the need for separate auxiliary attachment and removal steps that complicate traditional syntheses
Solution Approach 2:
The palladium catalyst with chiral ligands serves as an intermediary that facilitates the asymmetric synthesis. This catalytic intermediary enables direct chiral C-4 construction through a well-defined mechanism, replacing the complex multi-step procedures with a streamlined catalytic process that is easier to control and execute
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a cost-effective and environmentally friendly route to Ezetimibe, achieving high activity and selectivity in synthesizing the chiral intermediate, thereby simplifying the synthesis of Ezetimibe while reducing costs and environmental impact.
Implementation Method 1
a palladium-catalyzed asymmetric allylic amination process with a chiral aromatic spiroketal bisphosphine ligand
Data Source
AI summary
A process for the production of ezetimibe and intermediates used in said process are disclosed. A kind of Morita-Baylis-Hillman adduct can be altered to chiral carboxylic acid derivatives of β-arylamino α-methylene with high activity and selectivity by means of ally lamination reaction, and the above carboxylic acid derivatives of β-arylamino α-methylene can be altered to the chiral intermediates of ezetimibe by means of simple conversion and further synthesized into the chiral drug ezetimibe. The synthesis route introduces chirality through the use of a chiral catalysis method, thereby avoiding the use of the chiral auxiliary oxazolidinone; and the route is economical and eco-friendly.